Fraudulent data disclosure is costly to a business's bottom line and reputation. Research has shown, that often times, compliance and internal control measures can be easily compromised and concealed quite effectively. Many of these publications look into expense fraud and the cost of inaction.
- Report to the Nations brief
- Report to the Nations
- Stop Medicare Fraud
- Pharmaceutical settlements
- Expense auditing tips
- Forest Laboratories 2016
- AMA Sunshine Act
- The hidden costs of free lunches
- HCFAC FY2015 Report
- Financial Conflict of Interest in Medicine
- Insys therapeutics
- OIG 2009-2016 Settlement Fact sheet (Pharmaceutical)
- 2018 Report to the Nations
- Novartis
- Pay to Prescribe
- Open Payments Data: Review of Accuracy, Precision, and Consistency
- DOJ bribery guidlines place greater importance on expense reporting
- Solutions To Reduce Fraud, Waste, And Abuse In HHS Programs